The FDA has authorized Merck’s COVID pill for home use — the second in two days

Posted by on December 23, 2021 11:22 am
Categories: US National Stories

A photo provided by Merck of its new pill, molnupiravir, to treat COVID-19. Copyright © 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A. All rights reserved.

The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.

(Image credit: Merck & Co., Inc.)

Leave a Reply

Your email address will not be published.